e-learning
resources
Berlin 2008
Monday, 06.10.2008
Lower respiratory tract infection: from outbreak to prognostic tests
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Penicillin-resistant
streptococcus pneumoniae
is a rare etiology of community-acquired pneumonia requiring hospitalization: results from the CAPO international cohort study
M. Mirsaeidi, P. Peyrani, A. Diaz Fuenzalida, J. Gonzalez, L. Marzoratti, I. Toala, L. Rivero, J. Ramirez, The CAPO Investigators (Louisville, KY, United States Of America; Santiago, Chile; Buenos Aires, Tucuman, Argentina)
Source:
Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Session:
Lower respiratory tract infection: from outbreak to prognostic tests
Session type:
Thematic Poster Session
Number:
2240
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Mirsaeidi, P. Peyrani, A. Diaz Fuenzalida, J. Gonzalez, L. Marzoratti, I. Toala, L. Rivero, J. Ramirez, The CAPO Investigators (Louisville, KY, United States Of America; Santiago, Chile; Buenos Aires, Tucuman, Argentina). Penicillin-resistant
streptococcus pneumoniae
is a rare etiology of community-acquired pneumonia requiring hospitalization: results from the CAPO international cohort study. Eur Respir J 2008; 32: Suppl. 52, 2240
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
A study of the prevalence of streptococcus pneumoniae serotypes in patients hospitalised for community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016
Community-acquired pneumonia due to
streptococcus pneumoniae
in hospitalized patients – mortality predictors
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008
The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
Community-acquired pneumonia (CAP) caused by
mycoplasma pneumoniae
or
chlamydophila pneumoniae
in children: Are there reliable signs/symptoms for clinical diagnostics?
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013
Community-acquired pneumonia in younger patients is an entity on its own
Source: Eur Respir J 2012; 39: 1156-1161
Year: 2012
Are there differences in Pneumonia sp. pneumoniae in patients with community-acquired pneumonia patients and institutionalized?
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009
Early mortality in patients with community-acquired pneumonia: causes and risk factors
Source: Eur Respir J 2008; 32: 733-739
Year: 2008
MRSA as a cause of community-acquired pneumonia
Source: Eur Respir J 2009; 34: 1013-1014
Year: 2009
Streptococcus pneumoniae
resistance pattern and its clinical implications
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006
The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010
Fast replicating strains of streptococcus pneumoniae are associated with severe community-acquired pneumonia
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns
Source: Eur Respir J 2002; 20: 20S-27S
Year: 2002
Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia
Source: Eur Respir J 2009; 34: 1148-1158
Year: 2009
Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor
Source: Eur Respir J 2004; 24 : 779-785
Year: 2004
Epidemiology of community-acquired pneumonia and nosocomial pneumonia
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006
Diagnostic challenge in community-acquired pneumonia and hospital-acquired pneumonia: risk factors and diagnostic methods for methicillin resistant
Staphylococcus aureus
Source: Annual Congress 2006 - Methicillin resistant
Staphylococcus aureus
(MRSA): a real hospital-based pathogen?
Year: 2006
Bacteraemia in outpatients with community-acquired pneumonia
Source: Eur Respir J 2016; 47: 654-657
Year: 2016
MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia
Source: Eur Respir J 2009; 34: 1470-1476
Year: 2009
Severe
Chlamydia pneumoniae
community-acquired pneumonia
Source: Eur Respir J 2003; 22: Suppl. 45, 545s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept